The results complement the data Novo Nordisk released last week, which found Wegovy slashed the risk of serious heart problems and heart-related death by 20%.
Federal Judge asks if Elon Musk was trying to ‘cozy up' with former President Trump during criminal probe
The study estimated that 93 million U.S. adults would meet the eligibility criteria for the STEP 1 trial, which studied people who are overweight or obese and excluded those with Type 2 diabetes. An estimated 83 million Americans without established cardiovascular disease would also experience heart health benefits after taking Wegovy for a decade.
The analysis did not estimate the additional events that might be prevented among eligible adults with established cardiovascular disease.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy shown to cut risk of stroke and heart attacks, company saysThe findings are the first to demonstrate that a weight-loss drug has medical benefits beyond weight reduction.
Read more »
Popular weight-loss drugs like Wegovy may raise risk of complications under anesthesiaPatients taking blockbuster drugs like Wegovy for weight loss may face potentially deadly complications if they need surgery or other procedures that require empty stomachs for anesthesia.
Read more »
Seeking Medicare coverage for weight loss drugs, pharma giant courts Black influencersPharmaceutical giant Novo Nordisk has turned to influential Black Americans in pursuit of what would be a lucrative victory.
Read more »
Wildfire smoke pauses the American Heart Association Fairbanks Heart WalkThe American Heart Association Fairbanks Heart Walk has been postponed to Sept. due to poor air quality.
Read more »
Football world mourns Alex Collins’ tragic death in motorcycle crash: ‘Heart is broken’Collins was a beloved running back who played for the Baltimore Ravens and Seattle Seahawks during his five seasons in the NFL.
Read more »